Inflammatory Bowel Diseases
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.5 | Q1 | 81.0% | 1.932 | Q1 | 94.9% |
| 2024 | 4.3 | Q1 | 80.3% | 1.780 | Q1 | 94.2% |
| 2023 | 4.5 | Q1 | 83.6% | 1.550 | Q1 | 93.0% |
| 2022 | 4.9 | Q2 | 82.2% | 1.834 | Q1 | 95.0% |
| 2021 | 7.3 | Q1 | 85.3% | 1.706 | Q1 | 94.5% |
| 2020 | — | — | 1.932 | Q1 | 95.3% | |
| 2019 | — | — | 1.753 | Q1 | 94.4% | |
| 2018 | — | — | 1.858 | Q1 | 94.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1536-4844
ISSN
1078-0998
country
UScoverage
1995-2026